Login Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

  • Watchlist

    Keep track of companies that you follow and research.

  • 10 Years of Data

    Full access to our data with predictions and indicators that we calculate daily.

  • Screener

    Full access to our screener with tons of custom values and customizable email notifications.

  • XLS Exports

    Excel export of financials and screeners you define and save.

Subscribe now
Screener Weekly Summary

Cardinal Health, Inc. CAH

Healthcare  —  Medical Distribution
S&P 500 Member Dividend Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Analyst Commentary Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Cardinal Health, Inc. (CAH) Business Profile

Company Overview

Cardinal Health, Inc. (CAH) is a leading global healthcare services and products company headquartered in Dublin, Ohio, United States. Founded in 1971 by Robert D. Walter, the company initially operated as a food wholesaler before transitioning into the healthcare sector. Over the decades, Cardinal Health has grown into one of the largest healthcare services companies in the world, serving over 60,000 locations globally. The company is publicly traded on the New York Stock Exchange under the ticker symbol CAH and is a Fortune 500 company.

Key leadership at Cardinal Health includes Jason Hollar, who serves as the Chief Executive Officer (CEO). Hollar brings extensive experience in healthcare and business strategy, steering the company toward innovation and operational excellence. Other notable executives include Patricia English, Chief Financial Officer (CFO), and Jessica L. Mayer, Chief Legal and Compliance Officer.

Core Business Segments

Cardinal Health operates through two primary business segments: Pharmaceutical and Medical. These segments encompass a wide range of products and services that cater to healthcare providers, pharmacies, and patients worldwide.

Pharmaceutical Segment

The Pharmaceutical segment is the largest revenue generator for Cardinal Health. It focuses on the distribution of branded and generic pharmaceuticals, specialty drugs, and over-the-counter healthcare products. Key offerings include:

  • Pharmaceutical Distribution: Cardinal Health provides efficient and reliable distribution services to retail pharmacies, hospitals, and other healthcare providers.
  • Specialty Solutions: This includes services for specialty drugs, such as oncology and rheumatology medications, as well as consulting services for healthcare providers.
  • Nuclear and Precision Health Solutions: Cardinal Health operates one of the largest radiopharmaceutical networks in the U.S., offering diagnostic imaging agents and therapeutic radiopharmaceuticals.

Medical Segment

The Medical segment focuses on the manufacturing and distribution of medical, surgical, and laboratory products. Key offerings include:

  • Cardinal Health Brand Products: A wide range of medical and surgical products, including gloves, gowns, and wound care items.
  • Kitting Services: Custom procedure trays and kits tailored to specific medical procedures.
  • Medical Equipment: Distribution of durable medical equipment and consumables.
  • Supply Chain Services: Inventory management and logistics solutions for healthcare providers.

Business Model

Cardinal Health operates on a business-to-business (B2B) model, integrating its products and services to create value for healthcare providers and patients. The company generates revenue through the sale of pharmaceuticals, medical products, and value-added services such as supply chain management, consulting, and data analytics.

The company’s approach emphasizes operational efficiency, leveraging its extensive distribution network and technological capabilities to ensure timely delivery of products. Cardinal Health also focuses on building long-term partnerships with healthcare providers, offering customized solutions to meet their unique needs.

Strategic Direction

Cardinal Health is committed to driving growth through innovation, operational excellence, and strategic investments. Key areas of focus include:

  • Expansion of Specialty Solutions: The company aims to strengthen its position in the specialty pharmaceuticals market by expanding its product portfolio and enhancing support services for healthcare providers.
  • Digital Transformation: Cardinal Health is investing in advanced technologies such as artificial intelligence (AI) and data analytics to improve supply chain efficiency and customer experience.
  • Sustainability Goals: The company is dedicated to reducing its environmental footprint by adopting sustainable practices in its operations and supply chain.
  • New Product Categories: Cardinal Health is exploring opportunities in emerging healthcare markets, including telehealth and home-based care solutions.

Competitive Landscape

Cardinal Health operates in a highly competitive industry, facing competition from both large multinational corporations and smaller regional players. Key competitors include:

  • McKesson Corporation: A leading healthcare services and information technology company.
  • AmerisourceBergen Corporation: A major pharmaceutical sourcing and distribution services provider.
  • Medline Industries: A privately held manufacturer and distributor of medical supplies.
  • Owens & Minor, Inc.: A healthcare logistics company specializing in medical and surgical products.

Despite the competition, Cardinal Health differentiates itself through its extensive distribution network, diverse product portfolio, and commitment to innovation.

Risk Factors

Cardinal Health faces several risks that could impact its operations and financial performance, including:

  • Market Dependence: The company relies heavily on the U.S. healthcare market, making it vulnerable to changes in healthcare policies and regulations.
  • Supply Chain Disruptions: Global supply chain challenges, including raw material shortages and transportation delays, could affect product availability.
  • Pricing Pressure: Intense competition and pricing pressure in the pharmaceutical and medical supply markets could impact profit margins.
  • Regulatory Compliance: The healthcare industry is heavily regulated, and non-compliance with laws and regulations could result in fines and reputational damage.

Recent Developments

In recent years, Cardinal Health has implemented several strategic initiatives to enhance its market position and operational efficiency. Notable developments include:

  • Launch of Navista TS: A technology platform designed to support oncology practices in delivering value-based care.
  • Partnerships: Collaborations with leading healthcare organizations to expand access to specialty pharmaceuticals and improve patient outcomes.
  • Sustainability Initiatives: Introduction of eco-friendly packaging solutions and efforts to reduce greenhouse gas emissions.
  • Global Developments: The COVID-19 pandemic highlighted the importance of Cardinal Health’s role in ensuring the availability of critical medical supplies and pharmaceuticals.

Investment Considerations

Investors considering Cardinal Health should weigh the following strengths and risks:

Strengths

  • Market Leadership: Cardinal Health is a well-established leader in the healthcare services industry.
  • Diverse Product Portfolio: The company offers a wide range of products and services, reducing dependence on any single revenue stream.
  • Strong Distribution Network: Cardinal Health’s extensive distribution capabilities ensure timely delivery of products.
  • Commitment to Innovation: Investments in technology and sustainability position the company for long-term growth.

Risks

  • Regulatory Challenges: The healthcare industry is subject to stringent regulations, which could impact operations.
  • Economic Uncertainty: Global economic conditions and healthcare spending trends could affect demand for the company’s products and services.
  • Competitive Pressure: Intense competition in the healthcare sector could impact market share and profitability.

Conclusion

Cardinal Health, Inc. is a key player in the global healthcare services industry, offering a comprehensive range of products and services to healthcare providers and patients. With a strong focus on innovation, sustainability, and operational excellence, the company is well-positioned for future growth. However, investors should remain mindful of the risks associated with regulatory compliance, market dependence, and competitive pressures. Overall, Cardinal Health’s strategic initiatives and market leadership make it a compelling choice for stakeholders in the healthcare sector.